ENSG00000223804 and cancer: In this study, we reason that cancer cells with genomic instability or repair defects are particularly sensitive to the loss of both TC-HR and Alt-NHEJ pathways, providing the basis for the combination therapy using TRDMT1i and PARPi or Polθi.